Multimorbidity in Atrial Fibrillation: Impact on Outcomes
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.124.040612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Sheila M Manemann und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quantitative Health Sciences Mayo Clinic Rochester MN USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Multimorbidity is common in patients with atrial fibrillation (AF); however, the impact of the number and type of comorbid conditions on outcomes remains uncertain.
Methods
This cohort study included patients with new‐onset AF from a Midwest region between 2013 and 2017. Eighteen chronic conditions at the time of AF were classified into groups: cardiometabolic, other somatic, and mental health. Cox regression determined associations between the number of each condition type with death, ischemic stroke/transient ischemic attack, and congestive heart failure, stratified by age.
Results
Among 16 509 patients with AF (mean age, 74 years; 43% women), the mean number of cardiometabolic, other somatic, and mental health conditions was 2.7, 1.4, and 0.5, respectively. The number and type of conditions had a varying impact on outcomes and differed by age. A higher number of cardiometabolic conditions were associated with increased risk of death within 90 days only in people aged ≥85 years (≥4 conditions versus 0: hazard ratio [HR], 1.74 [95% CI, 1.05–2.87]), whereas for death after 90 days, associations were strongest in the youngest age group (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Quantitative Health Sciences Mayo Clinic Rochester MN USA.
- Department of Epidemiology, Rollins School of Public Health Emory University Atlanta GA USA.
- Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.
- Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute National Institutes of Health Bethesda MD USA.
ORCID-Profile: Alvaro Alonso, Peter A Noseworthy, Konstantinos C Siontis, Bernard J Gersh, Véronique L Roger, Jill M Killian, Lisa E Vaughan, Alanna M Chamberlain
Zitieren
APA
Manemann, S. M., Alonso, A., Noseworthy, P. A., Siontis, K. C., Gersh, B. J., Roger, V. L., Ryu, E., Killian, J. M., Weston, S. A., Vaughan, L. E., & Chamberlain, A. M. (2026). Multimorbidity in Atrial Fibrillation: Impact on Outcomes. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.040612
Vancouver
Manemann SM, Alonso A, Noseworthy PA, Siontis KC, Gersh BJ, Roger VL, et al. Multimorbidity in Atrial Fibrillation: Impact on Outcomes. Journal of the American Heart Association. 2026. doi:10.1161/jaha.124.040612
BibTeX
@article{Manemann2026,
author = {Manemann, Sheila M and Alonso, Alvaro and Noseworthy, Peter A and Siontis, Konstantinos C and Gersh, Bernard J and Roger, Véronique L and Ryu, Euijung and Killian, Jill M and Weston, Susan A and Vaughan, Lisa E and Chamberlain, Alanna M},
title = {Multimorbidity in Atrial Fibrillation: Impact on Outcomes},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.124.040612}
}
EUVIMED